You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 124 No. 5, May 1988 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  PATHOGENESIS, CLINICAL FEATURES AND MANAGEMENT OF THE NON-DERMATOLOGICAL COMPLICATIONS OF EPIDERMOLYSIS BULLOSA
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Tissue Stress and Tumor Promotion

Possible Relevance to Epidermolysis Bullosa

Gregory I. Goldberg, PhD; Arthur Z. Eisen, MD; Eugene A. Bauer, MD

Arch Dermatol. 1988;124(5):737-741.


Abstract



• Cutaneous carcinomas often arise in patients with severe epidermolysis bullosa (or other cutaneous ulcers) at multiple primary sites. Chronic tissue stress thus appears to promote carcinogenesis in preexisting somatic mutants in a stem cell population. Altered contractile properties of fibroblasts cultured from skin with epidermolysis bullosa may result from an altered interaction of these cells with their surrounding, chronically stressed, connective tissue matrix.

(Arch Dermatol 1988;124:737-741)



Author Affiliations



From the Division of Dermatology, Washington University School of Medicine, St Louis.


Footnotes



Accepted for publication Sept 14, 1987.

Presented in part at the Workshop on the Pathogenesis, Clinical Features, and Management of the Non-Dermatological Complications of Epidermolysis Bullosa, National Institutes of Health, Bethesda, Md, Sept 8, 1986.

Reprint requests to the Division of Dermatology, Washington University School of Medicine, 660 Euclid Ave, St Louis, MO 63110 (Dr Goldberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen
Martins et al.
J. Cell Sci. 2009;122:1788-1799.
ABSTRACT | FULL TEXT  

Squamous Cell Carcinoma in Epidermolysis Bullosa
Nair et al.
INT J LOW EXTREM WOUNDS 2004;3:100-102.
ABSTRACT  

Malignant Melanoma and a Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa
Chorny et al.
Arch Dermatol 1993;129:1212-1212.
ABSTRACT  

Head and Neck Manifestations of Epidermolysis Bullosa
Schaffer
CLIN PEDIATR 1992;31:81-88.
ABSTRACT  

Recessive Dystrophic Epidermolysis Bullosa Skin Displays a Chronic Growth-Activated Immunophenotype: Implications for Carcinogenesis
Smoller et al.
Arch Dermatol 1990;126:78-83.
ABSTRACT  

Natural Killer Cell Activity Is Reduced in Patients With Severe Forms of Inherited Epidermolysis Bullosa
Tyring et al.
Arch Dermatol 1989;125:797-800.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.